References
- Adada, M.M., Canals, D., Jeong, N., Kelkar, A.D., Hernandez-Corbacho, M., Pulkoski-Gross, M.J., Donaldson, J.C., Hannun, Y.A., and Obeid, L.M. (2015). Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion. FASEB J. 29, 4654-4669. https://doi.org/10.1096/fj.15-274340
- Beckham, C.J., Olsen, J., Yin, P.N., Wu, C.H., Ting, H.J., Hagen, F.K., Scosyrev, E., Messing, E.M., and Lee, Y.F. (2014). Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J. Urol. 192, 583-592. https://doi.org/10.1016/j.juro.2014.02.035
- Bramswig, K.H., Poettler, M., Unseld, M., Wrba, F., Uhrin, P., Zimmermann, W., Zielinski, C.C., and Prager, G.W. (2013). Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis. Cancer Res. 73, 6584-6596. https://doi.org/10.1158/0008-5472.CAN-13-0123
- Colas, E., Perez, C., Cabrera, S., Pedrola, N., Monge, M., Castellvi, J., Eyzaguirre, F., Gregorio, J., Ruiz, A., Llaurado, M., et al. (2011). Molecular markers of endometrial carcinoma detected in uterine aspirates. Int. J. Cancer 129, 2435-2444. https://doi.org/10.1002/ijc.25901
- Frantzi, M., Latosinska, A., Fluhe, L., Hupe, M.C., Critselis, E., Kramer, M.W., Merseburger, A.S., Mischak, H., and Vlahou, A. (2015). Developing proteomic biomarkers for bladder cancer: towards clinical application. Nat. Rev. Urol. 12, 317-330. https://doi.org/10.1038/nrurol.2015.100
- Franzen, C.A., Blackwell, R.H., Todorovic, V., Greco, K.A., Foreman, K.E., Flanigan, R.C., Kuo, P.C., and Gupta, G.N. (2015). Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes. Oncogenesis 4, e163. https://doi.org/10.1038/oncsis.2015.21
- Jiang, L., Phang, J.M., Yu, J., Harrop, S.J., Sokolova, A.V., Duff, A.P., Wilk, K.E., Alkhamici, H., Breit, S.N., Valenzuela, S.M., et al. (2014). CLIC proteins, ezrin, radixin, moesin and the coupling of membranes to the actin cytoskeleton: a smoking gun? Biochim. Biophys. Acta 1838, 643-657. https://doi.org/10.1016/j.bbamem.2013.05.025
- King, H. W., Michael, M. Z., and Gleadle, J. M. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12, 421. https://doi.org/10.1186/1471-2407-12-421
- Kalluri, R. (2016). The biology and function of exosomes in cancer. J. Clin. Invest. 126, 1208-1215. https://doi.org/10.1172/JCI81135
- Larion, S., Caballes, F.R., Hwang, S.I., Lee, J.G., Rossman, W.E., Parsons, J., Steuerwald, N., Li, T., Maddukuri, V., Groseclose, G., et al. (2013). Circadian rhythms in acute intermittent porphyria--a pilot study. Eur. J. Clin. Invest. 43, 727-739. https://doi.org/10.1111/eci.12102
- Lee, J., McKinney, K.Q., Pavlopoulos, A.J., Han, M.H., Kim, S.H., Kim, H.J., and Hwang, S. (2016). Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. Clin. Chim Acta 462, 118-126. https://doi.org/10.1016/j.cca.2016.09.001
- Mathivanan, S., and Simpson, R.J. (2009). ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000. https://doi.org/10.1002/pmic.200900351
- Nielsen, T.O., Borre, M., Nexo, E., and Sorensen, B.S. (2015). Coexpression of HER3 and MUC1 is associated with a favourable prognosis in patients with bladder cancer. BJU Int. 115, 163-165. https://doi.org/10.1111/bju.12658
- Pavelka, N., Pelizzola, M., Vizzardelli, C., Capozzoli, M., Splendiani, A., Granucci, F., and Ricciardi-Castagnoli, P. (2004). A power law global error model for the identification of differentially expressed genes in microarray data. BMC Bioinformatics 5, 203. https://doi.org/10.1186/1471-2105-5-203
- Piao, J., Liu, S., Xu, Y., Wang, C., Lin, Z., Qin, Y., and Liu, S. (2015). Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Exp. Mol. Pathol. 98, 1-6. https://doi.org/10.1016/j.yexmp.2014.11.003
- Stern, N., Markel, G., Arnon, T.I., Gruda, R., Wong, H., Gray-Owen, S.D., and Mandelboim, O. (2005). Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. J. Immunol. 174, 6692-6701. https://doi.org/10.4049/jimmunol.174.11.6692
- Suzuki, Y., Sutoh, M., Hatakeyama, S., Mori, K., Yamamoto, H., Koie, T., Saitoh, H., Yamaya, K., Funyu, T., Habuchi, T., et al. (2012). MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. Int. J. Oncol. 40, 1831-1838.
- Wang, Y., Yago, T., Zhang, N., Abdisalaam, S., Alexandrakis, G., Rodgers, W., and McEver, R.P. (2014). Cytoskeletal regulation of CD44 membrane organization and interactions with E-selectin. J. Biol. Chem. 289, 35159-35171. https://doi.org/10.1074/jbc.M114.600767
- Watts, J.A., Lee, Y.Y., Gellar, M.A., Fulkerson, M.B., Hwang, S.I., and Kline, J.A. (2012). Proteomics of microparticles after experimental pulmonary embolism. Thrombosis Res. 130, 122-128. https://doi.org/10.1016/j.thromres.2011.09.016
- Wood, S.L., Knowles, M.A., Thompson, D., Selby, P.J., and Banks, R.E. (2013). Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers. Nat. Rev. Urol. 10, 206-218. https://doi.org/10.1038/nrurol.2013.24
- Yang, L., Wu, X.H., Wang, D., Luo, C.L., and Chen, L.X. (2013). Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol. Med. Rep. 8, 1272-1278. https://doi.org/10.3892/mmr.2013.1634
Cited by
- Urinary Markers in Bladder Cancer: An Update vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00362
- Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond vol.19, pp.9, 2018, https://doi.org/10.3390/ijms19092822
- Frizzled-10 Extracellular Vesicles Plasma Concentration Is Associated with Tumoral Progression in Patients with Colorectal and Gastric Cancer vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/2715968
- Urinary proteomic biomarkers in oncology: ready for implementation? vol.16, pp.1, 2018, https://doi.org/10.1080/14789450.2018.1547193
- Protein Composition Reflects Extracellular Vesicle Heterogeneity vol.19, pp.8, 2018, https://doi.org/10.1002/pmic.201800167
- Urinary exosomal proteins as (pan‐)cancer biomarkers: insights from the proteome vol.593, pp.13, 2018, https://doi.org/10.1002/1873-3468.13487
- Advances in exosome isolation methods and their applications in proteomic analysis of biological samples vol.411, pp.21, 2018, https://doi.org/10.1007/s00216-019-01982-0
- Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers vol.20, pp.2, 2020, https://doi.org/10.1080/14737159.2020.1699791
- Moesin ( MSN ) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology vol.12, pp.4, 2020, https://doi.org/10.3390/cancers12041018
- Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles vol.12, pp.6, 2018, https://doi.org/10.3390/cancers12061400
- Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer vol.12, pp.9, 2018, https://doi.org/10.3390/cancers12092335
- Exosomes: A Source for New and Old Biomarkers in Cancer vol.12, pp.9, 2020, https://doi.org/10.3390/cancers12092566
- Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash Is Another Man’s Treasure vol.13, pp.3, 2021, https://doi.org/10.3390/cancers13030422
- Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances vol.13, pp.7, 2021, https://doi.org/10.3390/cancers13071529
- Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules vol.22, pp.13, 2018, https://doi.org/10.3390/ijms22136816
- Epigenetic extracellular vesicle-based biomarkers for urological malignancies: is the hope worth the hype? vol.13, pp.19, 2021, https://doi.org/10.2217/epi-2021-0333
- Molecular Profile Study of Extracellular Vesicles for the Identification of Useful Small “Hit” in Cancer Diagnosis vol.11, pp.22, 2018, https://doi.org/10.3390/app112210787